These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

155 related articles for article (PubMed ID: 15213673)

  • 1. [Precancerous lesions of the esophagus].
    Robaszkiewicz M
    Gastroenterol Clin Biol; 2004 May; 28(5 Suppl):D130-9. PubMed ID: 15213673
    [No Abstract]   [Full Text] [Related]  

  • 2. Summaries for patients. Cost-effectiveness of screening and surveillance for Barrett esophagus.
    Ann Intern Med; 2003 Feb; 138(3):I-41. PubMed ID: 12558382
    [No Abstract]   [Full Text] [Related]  

  • 3. [Barrett esophagus: features of structure and diagnostic tactics].
    Gomoliako IV; Bogomolets VV; Klochkova NE
    Klin Khir; 1996; (5):46-9. PubMed ID: 8991687
    [No Abstract]   [Full Text] [Related]  

  • 4. The role of quantitative pathology in clinical decision making for Barrett's oesophagus.
    Polkowski W; van Lanschot JJ; van Sandick JW; Baak JP
    Anal Cell Pathol; 2003; 25(3):123-7. PubMed ID: 12775916
    [No Abstract]   [Full Text] [Related]  

  • 5. Cardiac mucosa indicates risk for Barrett esophagus.
    Lenglinger J; Ringhofer C; Riegler FM
    World J Gastroenterol; 2006 Aug; 12(32):5259. PubMed ID: 16937547
    [No Abstract]   [Full Text] [Related]  

  • 6. Esophageal carcinoma.
    Rustgi AK; El-Serag HB
    N Engl J Med; 2014 Dec; 371(26):2499-509. PubMed ID: 25539106
    [No Abstract]   [Full Text] [Related]  

  • 7. Benign and precursor lesions in the esophagus.
    Akiyama J; Bertelé A; Brock C; Hvid-Jensen F; Ichiya T; Krarup AL; Majewski M; Rubio CA; Sarosiek J; Scarpignato C; Schmidt PT; Teich S; Triadafilopoulos G; Wallner G
    Ann N Y Acad Sci; 2014 Sep; 1325():226-41. PubMed ID: 25266028
    [TBL] [Abstract][Full Text] [Related]  

  • 8. From reflux esophagitis to Barrett's esophagus and esophageal adenocarcinoma.
    Wang RH
    World J Gastroenterol; 2015 May; 21(17):5210-9. PubMed ID: 25954094
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Managing Barrett esophagus.
    Harris P
    Nurse Pract; 2010 May; 35(5):21-3. PubMed ID: 20395762
    [No Abstract]   [Full Text] [Related]  

  • 10. An oncofetal protein IMP3: a new molecular marker for the detection of esophageal adenocarcinoma and high-grade dysplasia.
    Lu D; Vohra P; Chu PG; Woda B; Rock KL; Jiang Z
    Am J Surg Pathol; 2009 Apr; 33(4):521-5. PubMed ID: 19047899
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Topic Complex VI: Barrett esophagus].
    Messmann H; Ell C; Fein M; Kiesslich R; Ortner M; Porschen R; Stolte M
    Z Gastroenterol; 2005 Feb; 43(2):184-90. PubMed ID: 15700212
    [No Abstract]   [Full Text] [Related]  

  • 12. [Endobrachyesophagus].
    Riemann JF
    Dtsch Med Wochenschr; 1994 Jan; 119(1-2):42-3. PubMed ID: 8281882
    [No Abstract]   [Full Text] [Related]  

  • 13. Total endoscopic eradication of Barrett's esophagus: study methodology, candidate selection, and clinical outcomes.
    Shaheen NJ; Spechler SJ
    Endoscopy; 2008 Dec; 40(12):994-9. PubMed ID: 19065482
    [No Abstract]   [Full Text] [Related]  

  • 14. Detecting dysplasia with optical coherence tomography.
    Wallace MB
    Clin Gastroenterol Hepatol; 2006 Jan; 4(1):36-7. PubMed ID: 16431302
    [No Abstract]   [Full Text] [Related]  

  • 15. Pathogenesis of columnar-lined esophagus.
    Bani-Hani KE; Bani-Hani BK
    World J Gastroenterol; 2006 Mar; 12(10):1521-8. PubMed ID: 16570343
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Barrett carcinoma of the esophagus: clinical and radiographic analysis of 34 cases.
    Agha FP
    AJR Am J Roentgenol; 1985 Jul; 145(1):41-6. PubMed ID: 3873854
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Should people with Barrett's esophagus, who are at risk for cancer of the esophagus, avoid alcohol?
    Enzinger PC
    Health News; 2004 Jun; 10(6):16. PubMed ID: 15199910
    [No Abstract]   [Full Text] [Related]  

  • 18. Screening and surveillance for Barrett esophagus in high-risk groups: a cost-utility analysis.
    Inadomi JM; Sampliner R; Lagergren J; Lieberman D; Fendrick AM; Vakil N
    Ann Intern Med; 2003 Feb; 138(3):176-86. PubMed ID: 12558356
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Management of cancer risk in Barrett's esophagus.
    Tan A; Macrae F
    J Gastroenterol Hepatol; 2011 Oct; 26(10):1485-92. PubMed ID: 21592226
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Endoluminal therapy for esophageal disease: an introduction.
    Wolfsen HC
    Gastrointest Endosc Clin N Am; 2010 Jan; 20(1):1-10, v. PubMed ID: 19951790
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.